Cancer Drugs Lift Lilly’s Outlook

Is Eli Lily & Co. (LLY) still blooming? Yesterday, the share price sank and then rose amid confusion surrounding data from an early-stage study of the company’s experimental Alzheimer’s drug, falling to an intra-day low of $81.50 and climbing as high as $86.80. Today, the shares inched lower in recent trading, even though the drug [...]